Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wrinkle-Filling Market-Leader Medicis Ready To Take On Juvederm

This article was originally published in The Gray Sheet

Executive Summary

Medicis says the superior formulation of its Restylane dermal filler will enable it to fend off looming competition from a lower-priced offering by pharmaceutical powerhouse Allergan
Advertisement

Related Content

Allergan’s Aesthetic Device Lineup Gains Momentum In 2nd Quarter
Allergan’s Aesthetic Device Lineup Gains Momentum In 2nd Quarter
Venture Capital Spending Up For Wide Range Of Devices
Venture Capital Spending Up For Wide Range Of Devices
Allergan’s Juvederm Dermal Filler Approved, But Market Will Wait
Allergan’s Juvederm Dermal Filler Approved, But Market Will Wait
Advertisement
UsernamePublicRestriction

Register

MT023687

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel